Orthopedic Soft Tissue Repair Market Report 2025

The orthopedic soft tissue repair market size has grown strongly in recent years. It will grow from $6.09 billion in 2024 to $6.54 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to advancements in surgical techniques, technological innovations in implants, sports-related injuries, aging population, regenerative medicine research.

The orthopedic soft tissue repair market size is expected to see strong growth in the next few years. It will grow to $9.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing geriatric population, rise in sports injuries, regenerative medicine development, minimally invasive procedures. Major trends in the forecast period include biological augmentation techniques, demand for minimally invasive procedures, advancements in implant technologies, focus on tissue engineering, personalized treatment approaches.

The rising occurrence of sports-related injuries is anticipated to drive the growth of the orthopedic soft tissue repair market in the coming years. Sports injuries refer to those injuries sustained while participating in sports or exercise activities. Orthopedic soft tissue repair techniques are utilized to mend muscles, blood vessels, fibrous tissue, and other supportive connective tissues that are damaged during athletic activities. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that approximately 56,000 sports injuries resulted in hospital admissions during the 2021-22 period. The highest hospitalization rates due to sports injuries were recorded among younger Australians aged 15 to 19. Consequently, the increasing incidence of sports-related injuries is propelling the growth of the orthopedic soft tissue repair market.

The aging global population is anticipated to contribute significantly to the expansion of the orthopedic soft tissue repair market. As individuals aged 65 and older, known as the geriatric population, become more prevalent, there is an increased such aslihood of soft tissue damage, ligament sprains, and tendon injuries. The World Health Organization reports that by 2030, one in six people globally will be 60 or older, with an estimated 2.1 billion individuals in this age group by 2050. Similarly, projections from the UK Parliament's House of Commons Library indicate that by 2043, seniors will constitute 24% of the total UK population, reaching 17.4 million people. The rise in the geriatric population is a significant factor propelling the growth of the orthopedic soft tissue repair market.

Major companies are strategically introducing innovative products, such as the soft tissue stabilization system, to maintain their competitive positions. This medical device aims to support and secure soft tissues such as ligaments or tendons, promoting healing and stability. For example, Paragon 28 Inc., a US-based medical device company, launched the TenoTac 2 Soft Tissue Stabilization System in May 2022. This system utilizes a threaded titanium implant with a spiked base to achieve and maintain soft tissue fixation, addressing toe contracture at its source. With a two-handed technique for correction, temporary fixation, and final implant placement, the TenoTac 2 Soft Tissue Stabilization System offers a sterile kit with two dorsal lengths to accommodate varying patient anatomies.

Market leaders in orthopedic soft tissue repair are also rolling out new products to enhance their market standing. Paragon 28 Inc. introduced the Grappler Suture Anchor System in May 2022, designed to address challenges in soft tissue tensioning and ligament reconstruction during acute foot and ankle procedures. The system features a drilling wire with a non-skive tip and laser line for safe and accurate drilling. It provides an alternative fixation option to limit implant migration and tension loss during intraoperative tissue reattachment, offering PEEK and titanium anchors for efficiency.

In June 2024, Stryker, a US-based medical equipment manufacturing company, acquired Artelon for an undisclosed amount. This acquisition aims to bolster Stryker's product portfolio in joint preservation and soft tissue reconstruction. Artelon specializes in innovative biomaterials specifically designed for soft tissue reinforcement and repair, particularly in the fields of sports medicine and extremities procedures. Based in Georgia, Artelon develops cutting-edge products aimed at enhancing the healing and reconstruction of ligaments and tendons, positioning Stryker to expand its offerings in these critical areas of medical treatment.

Major companies operating in the orthopedic soft tissue repair market include Arthrex Inc., DePuy Synthes Inc. - Johnson & Johnson, Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet, CONMED Corporation, Integra LifeSciences Holding Corporation, Smith & Nephew plc, LifeNet Health, Becton Dickinson and Company, MTF Biologics, Tissue Regenix Group plc, Medtronic plc, Conformis Corporation, DJO Global Inc., Olympus Corporation, Terumo Corporation, Bioventus Inc., Mitek Corporation, Aesculap AG & Co. KG, OsteoMed Ltd., NuVasive Inc., Exactech Inc., Globus Medical Inc.

North America was the largest region in the orthopedic soft tissue repair market in 2024. The regions covered in the orthopedic soft tissue repair market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthopedic soft tissue repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Orthopedic soft tissue repair involves the replacement of injured or damaged tissues with healthy tissues, encompassing various structures such as nerves, ligaments, blood vessels, muscles, tendons, and synovial membranes. Injuries to orthopedic soft tissues often result from sports and physical activities, as well as routine tasks and prolonged use of specific body parts.

The main procedures associated with orthopedic soft tissue repair include cruciate ligaments repair, rotator cuff repair, lateral epicondylitis treatment, Achilles tendinosis repair, pelvic organ prolapse, gluteal tendon repair, hip arthroscopy, biceps tenodesis, and others. Cruciate ligament repair is a surgical procedure aimed at replacing the anterior cruciate ligament in the knee with a tissue graft to restore function after an injury. These procedures are performed in various injury locations such as the knee, shoulder, hip, and small joints, with end-users including hospitals, ambulatory centers, and orthopedic clinics.

The orthopedic soft tissue repair market research report is one of a series of new reports that provides orthopedic soft tissue repair market statistics, including orthopedic soft tissue repair industry global market size, regional shares, competitors with an orthopedic soft tissue repair market share, detailed orthopedic soft tissue repair market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic soft tissue repair industry. This orthopedic soft tissue repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The orthopedic soft tissue repair market includes revenues earned by entities by providing vaginal prolapse, meniscal repair, and shoulder labrum procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.